Order by 3 pm and it ships the same day · Free delivery across India
Indigo PeptidesCertificate of analysis
Certificate
IP-COA-RT-261005
Issued
6 October 2026
Status
released

Retatrutide

Synthetic peptide agonist at the GIP, GLP-1 and glucagon receptors

BatchIP-RT-261001This is the code printed on your vial.
Applicable strengths
  • 5 mg
  • 10 mg
  • 20 mg
  • 30 mg
  • 50 mg
99.74%RP-HPLCSpecification ≥ 99.0%

Full analytical results

Tests and specifications

TestMethodSpecificationResultStatus
AppearanceVisual inspectionWhite to off-white lyophilised powderConformsPass
PurityRP-HPLC (C18, 214 nm, water/acetonitrile with 0.1% TFA)≥ 99.0%99.74%Pass
IdentityESI-MS[M+5H]5+ = 947.29 ± 0.50947.35Pass
Related substancesRP-HPLC, any single impurity≤ 1.0%0.14%Pass
Total peptide contentUV absorbance at 280 nm against reference standard≥ 80.0%92.4%Pass
Water contentKarl Fischer titration≤ 8.0%2.95%Pass
Acetate contentIon chromatography≤ 15.0%6.1%Pass
pH, 1% aqueous solutionPotentiometry at 25 °C4.0 to 7.55.5Pass
Bacterial endotoxinsKinetic chromogenic LAL< 1.0 EU/mg< 0.1 EU/mgPass
SterilityMembrane filtration (USP <71>)No growthNo growthPass
Residual solventsHeadspace GC-FID (USP <467>)Acetonitrile ≤ 410 ppm, methanol ≤ 3000 ppm, dichloromethane ≤ 600 ppm (ICH Q3C)ConformsPass
Elemental impuritiesICP-MS (USP <232> and <233>)Pb ≤ 5, Cd ≤ 2, As ≤ 15, Hg ≤ 3 µg/day (ICH Q3D, parenteral)ConformsPass

Chromatogram

Reversed-phase trace, Retatrutide, batch IP-RT-261001Reversed-phase HPLC trace. One dominant peak at 21.3 minutes, 99.74 percent of total peak area. Largest single impurity 0.14 percent.02505007501000051015202530mAURetention time (minutes)21.3 min99.74% area

Reversed-phase trace for this batch. One dominant peak at 21.3 minutes, 99.74% of the total peak area, largest single impurity 0.14%.

Mass spectrum

ESI mass spectrum, Retatrutide, batch IP-RT-261001Electrospray ionisation mass spectrum. Base peak 947.35 m/z, charge state 5, expected 947.29.02550751006008001000120014001600Relative intensity (%)m/z7+6+947.35[M+5H]5+4+3+

Electrospray ionisation. Expected 947.29, observed 947.35, a difference of 0.06 m/z at charge state 5. The neighbouring peaks are the same molecule at the charge states either side of it.

Reference data

Also known as
LY3437943
CAS number
2381089-83-2
Molecular formula
C221H342N46O68
Molecular weight
4731.42 g/mol
Sequence
YXQGTFTSDYSIXLDKKAQXAFIEYLLEGGPSSGAPPPS
Modifications
X marks a residue with no one-letter code: Aib at 2 and 20, alpha-methyl-leucine at 13. The C-terminus is amidated, and the Lys17 side chain carries one AEEA spacer, then gamma-glutamyl, then a C20 fatty diacid.

Public reference values for the compound, not measurements on this batch. The batch measurements are in the table above.

Storage and handling

Unopened
2 to 8 °C, away from light
Long term
−20 °C, lyophilised, for the stated shelf life
Reconstituted
2 to 8 °C, use within 4 weeks; avoid repeated freeze and thaw
In transit
Stable at ambient temperature for up to 30 days
Reconstitute with
Bacteriostatic water

The vial this covers

The label on your vial carries the same batch code as this certificate, IP-RT-261001, and the QR goes to the results for it. If the code on the vial is not this one, the certificate for it is on this page under earlier batches.

Sticker shown at its printed size, 40 by 20 mm. Cap colour may vary by batch.

Release

Batch date
1 October 2026
Analysis date
4 October 2026
Issue date
6 October 2026
Best before
October 2028
Released by
Quality review, Indigo Peptides
Document
Valid only in its original, unmodified form

Results are taken from the batch testing documentation for this exact batch, supplied with the finished vials and held on file by us. Every value above is for the batch named on this certificate and for no other.

Holding an older vial?

BatchpurityAnalysed
IP-RT-26091099.57%13 September 2026

If the code on your vial is one of these, it is an earlier batch of ours and these are its results. A result we have published is never removed and never recalculated.